Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of Oct. 17:

CRISPR Therapeutics – Basel, Switzerland, 4.7 million shares, priced $15-$17, managed by Citi. Proposed symbol CRSP. Business: Preclinical biotech developing CRISPR/Cas9 gene editing therapies.

Forterra – Irving, Texas, 18.4 million shares, priced $19-$21, managed by Goldman Sachs. Proposed symbol FRTA. Business: Leading drainage and potable water pipe company in the US and Eastern Canada.

iRhythm Technologies – San Francisco, 5.35 million shares, priced $13-$15, managed by J.P. Morgan. Proposed symbol IRTC. Business: Provides a device and analysis for detecting cardiac arrhythmias.